Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00474669 · ClinicalTrials.gov registry record · Phase 1
A Phase I Study of Intraperitoneal Hyperthermic Docetaxel
A Phase 1 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00474669 is a Phase 1 study that has completed, run by University of Louisville. The registered enrollment target is 30 participants.
The verdict
NCT00474669, a Phase 1 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The primary objective is to assess the maximum tolerated dose of docetaxel administered intraperitoneally with heat at the time of second-look surgery in patients with stage II/III ovarian carcinoma.
Interventions
- DRUG docetaxel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00474669
The ClinicalTrials.gov registry entry for NCT00474669 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which docetaxel is the first listed.
NCT00474669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00474669 about?
NCT00474669 is a clinical study titled "A Phase I Study of Intraperitoneal Hyperthermic Docetaxel". The primary objective is to assess the maximum tolerated dose of docetaxel administered intraperitoneally with heat at the time of second-look surgery in patients with stage II/III ovarian carcinoma.
What is the current status of trial NCT00474669?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2007-06. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00474669?
The interventions under investigation include: docetaxel (DRUG).
Who is sponsoring clinical trial NCT00474669?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.